Amylyx Pharmaceuticals (AMLX) Other financing activities (2021 - 2023)
Amylyx Pharmaceuticals (AMLX) posted quarterly Other financing activities of $347000.0 for Q4 2023, down 82.12% year-over-year from $1.9 million in Q4 2022, and down 64.74% quarter-over-quarter from $984000.0 in Q3 2023.
Amylyx Pharmaceuticals (AMLX) Other financing activities (2021 - 2023) Analysis & Trends
Amylyx Pharmaceuticals' Other financing activities history runs 3 years deep, the most recent figure standing at $347000.0 for Q4 2023.
- In Q4 2023, Other financing activities fell 82.12% year-over-year to $347000.0; the TTM figure through Dec 2023 stood at $7.0 million (up 219.51% YoY), while the FY2023 annual figure was $7.0 million, up 219.51% from the prior year.
- Other financing activities for Q4 2023 stood at $347000.0, down from $984000.0 in the prior quarter.
- The five-year high for Other financing activities was $200.9 million in Q1 2022, with the low at -$200.6 million in Q2 2022.
- The 3-year median for Other financing activities is $347000.0 (2023), against an average of $866000.0.
- Peak annual rise in Other financing activities reached 647954.84% in 2022, while the deepest fall reached 6688400.0% in 2022.
- Amylyx Pharmaceuticals' Other financing activities stood at $145000.0 in 2021, then surged by 1238.62% to $1.9 million in 2022, then plunged by 82.12% to $347000.0 in 2023.
- Business Quant data shows AMLX's Other financing activities at $347000.0 in Q4 2023, $984000.0 in Q3 2023, and $2.1 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Amylyx Pharmaceuticals | 4.34 Bn | 4.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 347,000.00 |
| Dec 31, 2023 | 347,000.00 |
| Sep 30, 2023 | 984,000.00 |
| Sep 30, 2023 | 984,000.00 |
| Jun 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Jun 30, 2022 | -200.65 Mn |
| Jun 30, 2022 | -200.65 Mn |
| Mar 31, 2022 | 200.90 Mn |
| Mar 31, 2022 | 200.90 Mn |
| Dec 31, 2021 | 145,000.00 |
| Dec 31, 2021 | 145,000.00 |
| Sep 30, 2021 | 164,000.00 |
| Sep 30, 2021 | 164,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |